The effects of acetazolamide and amiloride on tissue electrolytes, with reference to the teratogenesis of carbonic anhydrase inhibition.
D000086:Acetazolamide / Q000494:pharmacology*; D000136:Acid-Base Equilibrium; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001639:Bicarbonates / Q000097:blood / Q000494:pharmacology / Q000652:urine; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D002256:Carbonic Anhydrases / Q000378:metabolism*; D004232:Diuretics / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D009132:Muscles / Q000201:enzymology / Q000378:metabolism; D011188:Potassium / Q000097:blood / Q000378:metabolism* / Q000652:urine; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats; D012964:Sodium / Q000097:blood / Q000378:metabolism / Q000652:urine; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D001639:Bicarbonates; D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics; D011719:Pyrazines; D000584:Amiloride; D012964:Sodium; D002256:Carbonic Anhydrases; D000086:Acetazolamide; D011188:Potassium